Zepp Health (NYSE:ZEPP) Lowered to “Sell” Rating by Wall Street Zen

Zepp Health (NYSE:ZEPP) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Separately, Fundamental Research set a $56.28 price target on Zepp Health and gave the stock a “buy” rating in a research report on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Zepp Health presently has an average rating of “Hold” and a consensus price target of $56.28.

Zepp Health Stock Performance

ZEPP opened at $4.53 on Friday. The business’s 50-day simple moving average is $9.78 and its 200 day simple moving average is $17.20. Zepp Health has a 52-week low of $2.50 and a 52-week high of $61.85. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.67 and a current ratio of 0.88. The firm has a market capitalization of $66.43 million, a PE ratio of -1.80 and a beta of 1.78.

Institutional Investors Weigh In On Zepp Health

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Public Employees Retirement System of Ohio raised its holdings in Zepp Health by 61.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock valued at $41,000 after acquiring an additional 576 shares in the last quarter. Osaic Holdings Inc. lifted its holdings in shares of Zepp Health by 239.5% during the 4th quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock worth $223,000 after acquiring an additional 5,845 shares during the period. Dimensional Fund Advisors LP acquired a new stake in shares of Zepp Health during the 4th quarter worth approximately $241,000. Oasis Management Co Ltd. acquired a new stake in shares of Zepp Health during the 3rd quarter worth approximately $276,000. Finally, Capstone Capital Management Ltd bought a new position in Zepp Health in the fourth quarter valued at approximately $298,000. Institutional investors and hedge funds own 52.61% of the company’s stock.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.